Integer Holdings (NYSE:ITGR) is growing its footprint in Ireland with two expansion projects.
The medical device contract manufacturer is expanding its New Ross, Ireland, location by 80,000 ft². That project will “substantially increase” the facility’s high-volume guidewire and wire-based manufacturing capacity, Integer said.
Plano, Texas–based Integer is also building a new R&D and manufacturing facility in Galway, Ireland, to “provide local solutions for structural heart, neurovascular, and electrophysiology applications, enabling seamless transitions from R&D to operations,” the company said.
The first phase of construction will add around 70,000 ft² of R&D and manufacturing space.
In announcing the expansions, Integer highlighted its experts in Spiddal, Ireland, who specialize in complex braiding, textile, and impact coating and covering capabilities.
“The team offers comprehensive solutions, including medical textiles, absorbable stents, and biomaterial braiding, among others,” the company said.
Integer Cardio & Vascular President Payman Khales said the projects show the company’s commitment “to delivering unparalleled value to our partners.”
“With our recent expansions in Europe, we’re dramatically strengthening our local and global differentiated R&D and manufacturing capabilities,” Khales said in a news release. “Our aim is to streamline the supply chain and ensure a smooth transition from R&D to operations for both our European and global customers, helping to accelerate time to market for new product innovations.”
